Monday, October 10, 2005
Arnold Kriegstein, director of the Institute for Stem Cell and Tissue Biology, right, and Arvid Carlsson, professor emeritus of pharmacology, University of Gothenburg, Sweden, were among the panelists.
In a recent panel discussion held at UCSF’s Genentech Hall, seven prominent scientists pondered aloud the promise and pitfalls of stem cell research.
Excerpts from the evening are presented below. The full 90-minute discussion is available for viewing in Real Media as well. The evening’s moderator was David A. Kessler, MD, dean of UCSF’s School of Medicine and vice chancellor for medical affairs.
The panelists included:
•
J. Michael Bishop, MD, chancellor of UCSF, University Professor and Nobel laureate
Jeffrey Bluestone, PhD, director of the Diabetes Center at UCSF and professor of medicine
Arvid Carlsson, MD, emeritus professor of pharmacology, University of Gotehnburg, Sweden and Nobel laureate
Elena Gates, MD, professor and chair of the Department of Obstetrics, Gynecology and Reproductive Sciences at UCSF
Arnold Kriegstein, PhD, MD, director of the Developmental and Stem Cell Biology Program and professor of neurology at UCSF
Stanley Prusiner, MD, professor of neurology at UCSF and Nobel laureate
Renee Reijo Pera, PhD, associate professor of obstetrics, gynecology and reproductive sciences at UCSF.
|
| More than 550 people gathered for the Sept. 20 stem cell event, which was simulcast at other UCSF locations. Photos by Christine Jegan. |
• See
full event in Real Media
here
|
Kriegstein:
Defining a stem cell 
Reijo Pera:
Explaining the difference between human embryonic stem cells and adult
stem cells 
Bishop:
Explaining how stem cell research fits into scientific progress
Prusiner,
Carlsson, Kriegstein: Discussing the
potential of stem cell research to combat various brain diseases
Bluestone:
Discussing the potential of stem cell replacement therapy to cure diabetes
and the safety issues involved 
Gates:
Explaining the difference between reproductive cloning and therapeutic
cloning 
